Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1D-methylphenidate
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 84 💬
2Methylphenidate
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[7] 6, 13, 34, 84, 113, 179, 206 💬
3Methylphenidate (MPD)
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 6 💬
4Methylphenidate (overencapsulated)
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 84 💬
5Methylphenidate 10mg tablets
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 84 💬
6METHYLPHENIDATE HYDROCHLORIDE
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[2] 6, 13 💬
7Methylphenidate modified release
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
8Methylphenidate modified release 20 mg
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
9Methylphenidate modified release 30 mg
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
10Methylphenidate modified release 40 mg
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13 💬
11Methylphenidate Oral Solution
(D04999)		[1] Methylphenidate[1] Methylphenidate (D04999) 💬[2] SLC6A2,
SLC6A3 💬		[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 206 💬
12Methylphenidate, fluoxetin, risperidone
(D04999)		[3] Fluoxetine,
Methylphenidate,
Risperidone		[3] Fluoxetine ,
Risperidone ,
Methylphenidate (D04999) 💬		[5] DRD2,
HTR2A,
SLC6A2,
SLC6A3,
SLC6A4 💬		[14] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬[2] 179, 206 💬